{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:26:49Z","timestamp":1794230809872,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA300913"],"award-info":[{"award-number":["K08CA300913"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA021765"],"award-info":[{"award-number":["P30CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcyt.2026.102907","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:13:27Z","timestamp":1778584407000},"page":"102907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-1227","authenticated-orcid":false,"given":"Devin","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-7178","authenticated-orcid":false,"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Akel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9231-6840","authenticated-orcid":false,"given":"Timothy","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-5868","authenticated-orcid":false,"given":"Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey C.","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-4601","authenticated-orcid":false,"given":"Christopher","family":"DeRenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-2081","authenticated-orcid":false,"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-6706","authenticated-orcid":false,"given":"Aimee C.","family":"Talleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Paulina","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-9980","authenticated-orcid":false,"given":"Brandon M.","family":"Triplett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-488X","authenticated-orcid":false,"given":"Subodh","family":"Selukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8998-0732","authenticated-orcid":false,"given":"Rebecca","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102907_bib0001","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/bloodadvances.2021005564","article-title":"Tisagenlecleucel outcomes in relapsed\/refractory extramedullary ALL: a pediatric real world CAR consortium report","volume":"6","author":"Fabrizio","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102907_bib0002","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102907_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102907_bib0004","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1182\/bloodadvances.2021006293","article-title":"Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL","volume":"6","author":"Talleur","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102907_bib0005","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/blood.2019001641","article-title":"Toxicity and response after CD19-specific CAR T-cell therapy in pediatric\/young adult relapsed\/refractory B-ALL","volume":"134","author":"Curran","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102907_bib0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.2023020621","article-title":"CD19\/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL","volume":"143","author":"Ghorashian","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102907_bib0007","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.ymthe.2025.03.019","article-title":"Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia","volume":"33","author":"Dreyzin","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2026.102907_bib0008","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M(+) diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2026.102907_bib0009","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1038\/s41591-025-03874-6","article-title":"GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1\/2 trial","volume":"31","author":"Locatelli","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102907_bib0010","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1182\/bloodadvances.2025017011","article-title":"International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML","volume":"9","author":"Naik","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102907_bib0011","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41591-025-03513-0","article-title":"Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma","volume":"31","author":"Li","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102907_bib0012","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102907_bib0013","first-page":"443","article-title":"Chimeric antigen receptor therapy for hematological malignancies: a pediatric perspective from leukapheresis to infusion","volume":"23","author":"Moretti","year":"2025","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jcyt.2026.102907_bib0014","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/trf.14569","article-title":"Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma","volume":"58","author":"Ceppi","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2026.102907_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc971","article-title":"Targeting tumours with genetically enhanced T lymphocytes","volume":"3","author":"Sadelain","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcyt.2026.102907_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100051","article-title":"Low platelet counts and low CD4\/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma","volume":"2","author":"Jo","year":"2025","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.jcyt.2026.102907_bib0017","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/trf.18354","article-title":"Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells","volume":"65","author":"Vucinic","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2026.102907_bib0018","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI125423","article-title":"CD19 CAR T cell product and disease attributes predict leukemia remission durability","volume":"129","author":"Finney","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102907_bib0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccell.2023.11.011","article-title":"Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy","volume":"42","author":"Kaczanowska","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcyt.2026.102907_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102907_bib0021","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/2159-8290.CD-18-1314","article-title":"Naive T-cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers","volume":"9","author":"Das","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jcyt.2026.102907_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102769","article-title":"Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients","volume":"59","author":"Hutt","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcyt.2026.102907_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30062","article-title":"Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy","volume":"70","author":"Molina","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2026.102907_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.06.007","article-title":"Leukapheresis and tisagenlecleucel manufacturing outcomes in patients age <3 years with relapsed\/refractory acute lymphoblastic leukemia","volume":"29","author":"Fong","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2026.102907_bib0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/trf.18216","article-title":"Apheresis collection parameters for approved CAR T-cell products need to be standardized","volume":"65","author":"Mamo","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2026.102907_bib0026","first-page":"514","article-title":"Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian expert panel","volume":"21","author":"Leone","year":"2023","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jcyt.2026.102907_bib0027","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jca.21964","article-title":"Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies","volume":"37","author":"Thibodeaux","year":"2022","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2026.102907_bib0028","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41409-023-01957-x","article-title":"A guide to the collection of T-cells by apheresis for ATMP manufacturing-recommendations of the GoCART coalition apheresis working group","volume":"58","author":"Worel","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102907_bib0029","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(24)00319-2","article-title":"Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial","volume":"403","author":"D'Angelo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2026.102907_bib0030","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2352-3026(22)00378-7","article-title":"CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial","volume":"10","author":"Sallman","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jcyt.2026.102907_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.04.013","article-title":"A Clinically applicable prediction model to improve t cell collection in chimeric antigen receptor T Cell therapy","volume":"28","author":"Jo","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2026.102907_bib0032","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/trf.14003","article-title":"Autologous lymphapheresis for the production of chimeric antigen receptor T cells","volume":"57","author":"Allen","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2026.102907_bib0033","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jca.21812","article-title":"Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric\/adolescent acute lymphoblastic leukemia patients","volume":"35","author":"Jarisch","year":"2020","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2026.102907_bib0034","series-title":"Considerations for the development of chimeric antigen receptor (CAR) T cell products: guidance for industry","year":"2021"},{"key":"10.1016\/j.jcyt.2026.102907_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2019.229781","article-title":"Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)","volume":"105","author":"Yakoub-Agha","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2026.102907_bib0036","unstructured":"Novartis Pharmaceuticals Corporation. Novartis Leukapheresis Reference Manual: Version G2. East Hanover, NJ, 2020."},{"key":"10.1016\/j.jcyt.2026.102907_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.102038","article-title":"Establishing practical predictors of collection efficiency for optimized chimeric antigen receptor T-cell apheresis","volume":"28","author":"Kim","year":"2026","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102907_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110079","article-title":"CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia","volume":"37","author":"Zebley","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2026.102907_bib0039","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/2159-8290.CD-21-1508","article-title":"Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T-cell receptor lineages","volume":"12","author":"Wilson","year":"2022","journal-title":"Cancer Discov"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:18:08Z","timestamp":1785907088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1465324926008686"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102907","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102907"}}